HURA
トゥフラ・バイオサイエンシズ
TuHURA Biosciences, Inc.
プレマーケットデータ（自動更新なし）20日平均DV $1M?
Earnings 2026-08-1352W high -42.8%52W low +443.9%Fwd PER 27.9xMarket cap $142MAvg volume 499K
Company Overview
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2026 Q1 | -0.13 | $0 | -$4M |
| 2025 Q4 | -0.13 | $0 | -$6M |
| 2025 Q3 | -0.14 | $0 | -$11M |
| 2025 Q2 | -0.21 | $0 | -$6M |
| 2025 Q1 | -0.15 | $0 | -$5M |
| 2024 Q4 | -0.14 | $0 | -$3M |
| 2024 Q3 |
